Patients infected with HIV-1 undergoing protease inhibitor (PI) treatment have a reduced incidence or regression of Kaposi sarcoma (KS), but the molecular mechanism of this response remains unclear. In March
Sgadari
"These results indicate...
Patients infected with HIV-1 undergoing protease inhibitor (PI) treatment have a reduced incidence or regression of Kaposi sarcoma (KS), but the molecular mechanism of this response remains unclear. In March
Sgadari
"These results indicate...